ArticleJournal of clinical laboratory analysis2026
Reduced Serum Soluble L-Selectin Levels but Not PCSK9 May Be Associated With Generalized Anxiety Disorder: A Case-Control Study.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGeneralized anxiety disorder (GAD) is a complex psychiatric disorder characterized by constant, unconstrained worrying. This investigation aimed to explore the potential role of soluble L-selectin (sL-selectin) and proprotein convertase subtilisin/kexin type 9 (PCSK9) in the pathogenesis of GAD.
methodsThe study included 88 patients and 88 healthy controls (HCs) matched with age and sex. A psychiatrist confirmed the GAD diagnosis, assessed symptom severity using the GAD-7 scale, and evaluated controls based on the DSM-5 criteria. Serum levels of sL-selectin and PCSK9 were quantified using commercially available ELISA kits.
resultsSerum sL-selectin concentrations were notably lower in GAD patients than HCs (0.51 ± 0.07 μg/mL vs. 1.52 ± 0.18 μg/mL). Additionally, there was a significant inverse association between sL-selectin levels and GAD-7 scores (r = -0.359, p = 0.001). This sL-selectin also demonstrated strong predictive ability in the ROC investigation, with an area under the curve (AUC) of 0.718 (p < 0.001), indicating 64.3% sensitivity and 76.5% specificity at a threshold of 0.60 μg/mL. In contrast, no notable difference was observed for serum PCSK9 levels between GAD patients and HCs.
conclusionThis study provides a better understanding of the relationship between inflammatory cytokines and GAD pathogenesis. The results indicate that sL-selectin, rather than PCSK9, may be associated with the pathophysiology of GAD. Still, more advanced investigations with greater sample sizes and extensive studies are essential to verify the probable diagnostic utility of serum sL-selectin levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.